MSCI (NYSE:MSCI) Stock Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 01/08/2024 | 11.35% | Oppenheimer | $572 → $601 | Maintains | Outperform |
| 01/05/2024 | — | Raymond James | Downgrades | Outperform → Market Perform | |
| 12/13/2023 | 11.16% | Morgan Stanley | $526 → $600 | Upgrades | Equal-Weight → Overweight |
| 11/01/2023 | 5.6% | RBC Capital | → $570 | Reiterates | Outperform → Outperform |
| 11/01/2023 | 11.16% | Barclays | $650 → $600 | Maintains | Overweight |
| 11/01/2023 | -2.55% | Morgan Stanley | $532 → $526 | Maintains | Equal-Weight |
| 11/01/2023 | -1.25% | Raymond James | $577 → $533 | Maintains | Outperform |
| 10/18/2023 | 11.16% | JP Morgan | $610 → $600 | Maintains | Overweight |
| 10/05/2023 | 13.57% | Oppenheimer | $620 → $613 | Maintains | Outperform |
| 09/14/2023 | 2.64% | Redburn Partners | → $554 | Downgrades | Buy → Neutral |
| 07/27/2023 | 7.83% | Goldman Sachs | $510 → $582 | Maintains | Neutral |
| 07/26/2023 | -1.44% | Morgan Stanley | $515 → $532 | Maintains | Equal-Weight |
| 07/26/2023 | 0.97% | RBC Capital | → $545 | Reiterates | Outperform → Outperform |
| 07/26/2023 | 18.57% | Wells Fargo | $570 → $640 | Maintains | Overweight |
| 07/26/2023 | 20.42% | Barclays | $600 → $650 | Maintains | Overweight |
| 07/26/2023 | 9.68% | Raymond James | $574 → $592 | Maintains | Outperform |
| 07/17/2023 | -16.63% | Exane BNP Paribas | → $450 | Downgrades | Neutral → Underperform |
| 07/14/2023 | 6.34% | Raymond James | $570 → $574 | Maintains | Outperform |
| 07/05/2023 | 8.01% | Oppenheimer | $595 → $583 | Maintains | Outperform |
| 06/15/2023 | -12.92% | B of A Securities | → $470 | Initiates Coverage On | → Underperform |
| 05/09/2023 | 5.6% | Wells Fargo | → $570 | Initiates Coverage On | → Overweight |
| 04/26/2023 | 11.16% | RBC Capital | → $600 | Reiterates | → Outperform |
| 04/26/2023 | 10.23% | Oppenheimer | $600 → $595 | Maintains | Outperform |
| 04/26/2023 | -4.59% | Morgan Stanley | $551 → $515 | Maintains | Equal-Weight |
| 04/26/2023 | -5.51% | Goldman Sachs | $567 → $510 | Maintains | Neutral |
| 04/26/2023 | 5.6% | Raymond James | $574 → $570 | Maintains | Outperform |
| 04/19/2023 | 9.31% | JP Morgan | $585 → $590 | Maintains | Overweight |
| 04/13/2023 | 6.34% | Raymond James | $549 → $574 | Maintains | Outperform |
| 04/04/2023 | 11.16% | Oppenheimer | $575 → $600 | Maintains | Outperform |
| 03/27/2023 | 2.08% | Morgan Stanley | $543 → $551 | Maintains | Equal-Weight |
| 02/02/2023 | 8.38% | JP Morgan | $580 → $585 | Maintains | Overweight |
| 02/01/2023 | 0.6% | Morgan Stanley | $518 → $543 | Maintains | Equal-Weight |
| 02/01/2023 | 11.16% | RBC Capital | $520 → $600 | Maintains | Outperform |
| 02/01/2023 | 6.53% | Oppenheimer | $510 → $575 | Maintains | Outperform |
| 02/01/2023 | 1.71% | Raymond James | $539 → $549 | Maintains | Outperform |
| 01/04/2023 | -4.03% | Morgan Stanley | $500 → $518 | Maintains | Equal-Weight |
| 12/13/2022 | 7.46% | JP Morgan | → $580 | Initiates Coverage On | → Overweight |
| 12/02/2022 | 11.16% | Barclays | $470 → $600 | Maintains | Overweight |
| 10/26/2022 | -7.37% | Morgan Stanley | $505 → $500 | Maintains | Equal-Weight |
| 10/26/2022 | -4.77% | Raymond James | $499 → $514 | Maintains | Outperform |
| 10/20/2022 | -21.63% | Deutsche Bank | $513 → $423 | Maintains | Hold |
| 10/17/2022 | -7.55% | Raymond James | $510 → $499 | Maintains | Outperform |
| 08/16/2022 | -0.88% | Oppenheimer | $507 → $535 | Maintains | Outperform |
| 08/10/2022 | -4.96% | Deutsche Bank | $478 → $513 | Maintains | Hold |
| 07/29/2022 | 1.16% | UBS | $514 → $546 | Maintains | Buy |
| 07/27/2022 | -5.88% | Morgan Stanley | $515 → $508 | Maintains | Equal-Weight |
| 07/27/2022 | -5.51% | Raymond James | $493 → $510 | Maintains | Outperform |
| 07/20/2022 | -4.59% | Morgan Stanley | $540 → $515 | Maintains | Equal-Weight |
| 07/15/2022 | -8.66% | Raymond James | $515 → $493 | Maintains | Outperform |
| 06/28/2022 | -3.66% | RBC Capital | $600 → $520 | Maintains | Outperform |
| 06/24/2022 | -12.92% | Barclays | $570 → $470 | Maintains | Overweight |
| 04/28/2022 | -4.59% | Raymond James | → $515 | Upgrades | Market Perform → Outperform |
| 04/27/2022 | -11.63% | Deutsche Bank | $533 → $477 | Maintains | Hold |
| 04/27/2022 | 5.6% | Barclays | $700 → $570 | Maintains | Overweight |
| 04/27/2022 | 0.04% | Morgan Stanley | $593 → $540 | Maintains | Equal-Weight |
| 04/01/2022 | 2.45% | Goldman Sachs | → $553 | Initiates Coverage On | → Neutral |
| 03/30/2022 | -1.25% | Deutsche Bank | → $533 | Initiates Coverage On | → Hold |
| 01/28/2022 | 9.86% | Morgan Stanley | $651 → $593 | Maintains | Equal-Weight |
| 01/05/2022 | 20.61% | Morgan Stanley | $600 → $651 | Maintains | Equal-Weight |
| 10/27/2021 | 11.16% | Morgan Stanley | $570 → $600 | Maintains | Equal-Weight |
| 10/27/2021 | 32.1% | Oppenheimer | $685 → $713 | Maintains | Outperform |
| 09/23/2021 | 5.6% | Morgan Stanley | $523 → $570 | Maintains | Equal-Weight |
| 09/21/2021 | 33.39% | RBC Capital | $650 → $720 | Maintains | Outperform |
| 07/28/2021 | 11.16% | Deutsche Bank | $525 → $600 | Maintains | Buy |
| 07/28/2021 | -3.11% | Morgan Stanley | $480 → $523 | Maintains | Equal-Weight |
| 07/28/2021 | 15.98% | Oppenheimer | $566 → $626 | Maintains | Outperform |
| 07/08/2021 | 11.16% | RBC Capital | → $600 | Initiates Coverage On | → Outperform |
| 06/16/2021 | 0.6% | Oppenheimer | $533 → $543 | Maintains | Outperform |
| 05/27/2021 | -11.07% | Morgan Stanley | $473 → $480 | Maintains | Equal-Weight |
| 04/28/2021 | -12.37% | Morgan Stanley | $448 → $473 | Maintains | Equal-Weight |
| 04/28/2021 | -1.25% | Oppenheimer | $493 → $533 | Maintains | Outperform |
| 03/12/2021 | -12% | Deutsche Bank | → $475 | Initiates Coverage On | → Buy |
| 02/01/2021 | -14.22% | UBS | $452 → $463 | Upgrades | Neutral → Buy |
| 01/29/2021 | -17% | Morgan Stanley | $422 → $448 | Maintains | Equal-Weight |
| 01/06/2021 | -21.82% | Morgan Stanley | $391 → $422 | Maintains | Equal-Weight |
| 10/28/2020 | -27.56% | Morgan Stanley | $384 → $391 | Maintains | Equal-Weight |
| 10/20/2020 | -28.86% | Morgan Stanley | $366 → $384 | Maintains | Equal-Weight |
| 10/06/2020 | -22.93% | Oppenheimer | → $416 | Initiates Coverage On | → Outperform |
| 07/29/2020 | -30.52% | UBS | $342 → $375 | Maintains | Neutral |
| 07/29/2020 | -32.19% | Morgan Stanley | $337 → $366 | Maintains | Equal-Weight |
| 07/10/2020 | -37.56% | Morgan Stanley | $314 → $337 | Maintains | Equal-Weight |
| 07/08/2020 | -7.18% | BMO Capital | $346 → $501 | Maintains | Outperform |
| 04/30/2020 | -35.9% | BMO Capital | $311 → $346 | Maintains | Outperform |
| 04/29/2020 | -41.83% | Morgan Stanley | $299 → $314 | Maintains | Equal-Weight |
| 04/22/2020 | -44.61% | Morgan Stanley | $274 → $299 | Maintains | Equal-Weight |
| 04/01/2020 | -42.38% | BMO Capital | $336 → $311 | Maintains | Outperform |
| 03/13/2020 | -50.35% | UBS | $299 → $268 | Maintains | Neutral |
| 02/12/2020 | — | Atlantic Equities | Upgrades | Neutral → Overweight | |
| 01/31/2020 | -49.24% | Morgan Stanley | $255 → $274 | Maintains | Equal-Weight |
| 01/31/2020 | -37.94% | Wells Fargo | $270 → $335 | Maintains | Overweight |
| 01/31/2020 | -44.61% | UBS | $285 → $299 | Maintains | Neutral |
| 01/24/2020 | -52.76% | Morgan Stanley | $253 → $255 | Maintains | Equal-Weight |
| 11/04/2019 | -50.35% | BMO Capital | $252 → $268 | Maintains | Outperform |
| 11/01/2019 | -49.98% | Wells Fargo | $260 → $270 | Maintains | Outperform |
| 10/11/2019 | -59.61% | Buckingham Research | $222 → $218 | Maintains | Neutral |
| 10/02/2019 | -55.91% | UBS | $235 → $238 | Maintains | Neutral |
| 09/25/2019 | -56.46% | Atlantic Equities | → $235 | Initiates Coverage On | → Neutral |
| 07/19/2019 | -55.54% | Morgan Stanley | $223 → $240 | Maintains | Equal-Weight |
| 07/08/2019 | -52.2% | UBS | $234 → $258 | Downgrades | Buy → Neutral |
| 06/13/2019 | -58.69% | Morgan Stanley | $216 → $223 | Maintains | Equal-Weight |
| 01/25/2019 | -68.32% | Buckingham Research | → $171 | Initiates Coverage On | → Neutral |